Slide 1: 3Q 2022 Summary
3Q 2022 Earnings Commentary Revenue Adjusted Expense* Adjusted Diluted EPS 3Q 2022 Summary in millions • CME Group’s performance in 3Q and year-to-date (YTD) in 2022 highlights $1,400 $2.00 the effectiveness of our risk management solutions during a time where there is a tremendous amount of uncerta
Slide 2: 3Q Highlights
3Q 2022 Earnings Commentary - Unaudited 3Q Highlights CME Group’s highly diverse product set positions the (ADV and OI stated in contracts, except for cash markets) company well for varying macroeconomic backdrops • 3Q22 ADV increased 26% to 22.4 million, and Includes 3Q 2022 Includes was best 3Q AD
Slide 3: 3Q22 non-U.S. ADV was 6.1 million contracts, up 21% from 3Q21
3Q 2022 Earnings Commentary - Unaudited 3Q22 non-U.S. ADV was 6.1 million contracts, up 21% from 3Q21 • 3Q22 non-U.S. ADV highlights: Non-U.S. ADV by Product Line 3.2 • FX ADV up 36% ADV in millions • Interest Rates ADV up 32% 2.4 • Equity Index ADV up 25% • Options ADV up 16% 1.6 • EMEA region ADV
Slide 4: 3Q 2022 Highlights: new products and SOFR migration
3Q 2022 Earnings Commentary - Unaudited With a significant focus on the ever-evolving needs of market participants worldwide, CME Group continues to launch new products and services, as well as enhancements to existing offerings SOFR migration progressing well, and CME Group fallback plans communica
Slide 5: 3Q 2022 Product Detail - Financials and Commodities
3Q 2022 Earnings Commentary - Unaudited • Euro Short-Term Rate (€STR) – Announced launch for 4Q, based on strong client demand and pending regulatory review, these futures are for hedging overnight money market and repo rates exposure in Europe, which should be a valuable tool for market participant
Slide 6: Financial Results
3Q 2022 Earnings Commentary - Unaudited Financial Results • 3Q22 revenue was $1.2 billion. 3Q22 clearing and transaction fees revenue totaled $999 million including approximately $77 million of transaction revenue generated Dividends Declared* $ in millions from cash markets businesses (~$36 million
Slide 7: Financial Results Appendix: Micro Product Quarterly Details
3Q 2022 Earnings Commentary - Unaudited Financial Results Appendix Micro Product Quarterly Details ADV in thousands / RPC in cents except for Micro Crypto Micro Equity Index Products (including Micro Crypto) 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 ADV 1,961 2,004 2,499 1,891 1,858 2,286 3,437 3
Slide 8: Use of Non-GAAP Measures and Forward-Looking Statements
3Q 2022 Earnings Commentary - Unaudited Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation mate